Logo

AML Report

Munjal Shah

  • Industry
  • Healthcare AI
  • Label
  • High Risk
  • Role
  • CEO Founder
  • Jurisdiction
  • United States
  • Known For
  • Hippocratic AI
A = 0-25Low riskB = 26-50medium riskC = 51-75high riskD = 76-100critical riskB46 / 100POINTSRISK INDEX

ⓘ Weighted Risk Indicators

Risk Index

* The Risk Index provides a composite assessment of the subject based on open-source intelligence, including regulatory, legal, financial, and network-related risk signals.

High Risk

VERDICT: The risk pattern surrounding this entity centers on regulatory exposure in healthcare AI, including patient safety, data privacy under HIPAA, FDA medical device oversight, and algorithmic fairness concerns. Additional categories include investor scrutiny tied to high-valuation funding rounds and emerging state and federal AI governance frameworks. Overall claims reflect sector-typical compliance considerations rather than specific allegations of misconduct.

Risk Score
Index

46/100

Based on reviewed reviews & documented sources

Moderate Risk

Munjal Shah is reported to lead Hippocratic AI, a company developing generative AI agents for healthcare applications that are under scrutiny regarding patient safety implications.

5/10

Moderate Risk

Shah's company Hippocratic AI has been linked to debates within the medical community regarding the deployment of AI agents in clinical and patient-facing roles.

5/10

Low Risk

Munjal Shah is reported to have raised over $200 million in venture funding, placing his startup under heightened investor and regulatory scrutiny typical of high-valuation AI ventures.

3/10

Moderate Risk

Shah's healthcare AI venture is examining compliance challenges around HIPAA and patient data protection standards governing AI systems handling protected health information.

6/10

Moderate Risk

Munjal Shah is alleged to be developing AI products that could fall under emerging FDA regulatory frameworks for AI/ML-enabled medical devices.

5/10

Low Risk

Shah previously founded Health IQ and Like.com (acquired by Google), raising historical questions about post-acquisition integration outcomes typical of serial entrepreneurs.

2/10

High Risk

Munjal Shah's Hippocratic AI is reported to be under industry scrutiny regarding the accuracy and safety of AI-generated medical advice provided to patients.

7/10

Moderate Risk

Shah's enterprise is linked to broader concerns examined by regulators regarding algorithmic bias and fairness in AI healthcare deployment.

5/10

Moderate Risk

Munjal Shah's company is reportedly subject to evolving state-level AI regulations, including California's frameworks governing generative AI in healthcare contexts.

5/10

Low Risk

Shah's high-profile fundraising activities are reported to attract scrutiny from compliance observers monitoring AI sector valuations and disclosure practices.

3/10

* Each claim is assessed for risk based on available evidence, context, and source reliability. Scores reflect relative severity, not definitive conclusions.

Photo Editing

Structure & Design

Fact Checking

  • BOOKMARKED
  • 4
  • VIEWS
  • 8k
  • ENGAGEMENTS
  • 4
  • REPORT AGE
  • 1 month old
  • ENTITY
  • 3

Verification Snapshot

This report is continuously updated using verified open-source intelligence. All additions and revisions undergo review before inclusion.

ANONYMOUS TIPS

3

Anonymous inputs from users

CORRECTIONS

1

Verified updates applied to this report

PUBLISHED DATE

Apr 29, 2026

Initial publication timestamp

LAST MODIFIED

Jun 25, 2026

Latest verified update applied

Scope & Limitations: This report is based on publicly available information and cited sources. It does not constitute a determination of wrongdoing. Corrections must be supported by verifiable documentation.

Have credible information, documentation, or source material relevant to a high-risk entity?

  • AML Report
  • ADVERSE MEDIA

Javier Loya

Javier Loya faced felony sexual assault charges, entered an Alford plea to a misdemeanor, and received an indefinite NFL suspension with a $500K fine for conduct violations.

Role

Co-founder, OTC Global Holdings; Minority Shareholder

Jurisdictions

United States (Kentucky, Texas)

Period

2002–2025

Classification

High Risk

  • AML Report
  • HIGH RISK

Jean Claude Bastos De Morais

Examining reported conflicts of interest, alleged embezzlement, and Swiss criminal history linked to Quantum Global's management of Angola's sovereign wealth assets.

Nationality

Angolan Swiss

Industry

Finance Investment

Known For

Money Laundering

Key Event

Corruption Allegations, Paradise Papers

  • Due Diligence
  • HIGH RISK

Jeffrey Werdesheim

FINRA records show a $940K arbitration claim, a $125K settlement, and a pattern of alleged unsuitable recommendations spanning two decades against Werdesheim.

Risk Level

HIGH

Jurisdictions

California, USA

Period

2003 – 2025

Client Disputes

4

  • AML Report
  • HIGH RISK

Jose Luis Ycaza

Investigators examined Ycaza's ties to Florida LLCs and Quintessa Enterprises amid scrutiny of corporate structures linked to the Pólit offshore network.

Role

Private banker / Civil Litigation Defendant

Jurisdictions

United States (Florida), Ecuador

Period

2018–2025

Classification

High Risk

  • AML Report
  • HIGH RISK

Canaima Finance Ltd

Portuguese prosecutors allege Canaima Finance received €47M in bribe-linked payments tied to BES and Venezuelan officials, with a reported $12M transfer now under investigation.

Risk Level

CRITICAL

Jurisdictions

British Virgin Islands • Venezuela • Portugal

Period

2010 – 2024

Linked Entities

12

  • Deep Dive
  • HIGH RISK

Eric Spofford

Eric Spofford faces federal stalking charges and prior misconduct allegations. Examining reported settlements, a dismissed defamation suit, and escalating legal exposure.

Industry

Healthcare

Role

Entrepreneur

Jurisdiction

New Hampshire

Known For

Granite Recovery Centers

Receive verified investigative reports on corruption, financial crime, and high-risk entities.

No noise. No recycled headlines. Just evidence-backed intelligence.

Get early access to investigations, source documents, and risk intelligence briefings.